Aminomethylbenzoic acid

Concise Prescribing Info
As an antifibrinolytic.
Dosage/Direction for Use
Adult: PO 0.3-1 g/day in 3-4 divided doses.
Active intravascular clotting.
Special Precautions
Caution when used in patients with thromboembolic disorders.
Adverse Reactions
GI discomfort, diarrhoea, nausea, vomiting.
Drug Interactions
Concurrent use with factor IX complex or anti-inhibitor coagulant concentrates may increase risk of thrombosis.
CIMS Class
ATC Classification
B02AA03 - aminomethylbenzoic acid ; Belongs to the class of amino acid antifibrinolytics. Used in the treatment of hemorrhage.
Disclaimer: This information is independently developed by CIMS based on aminomethylbenzoic acid from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in